| One of the 20 Best Manufacturing Companies to Sell For, seven consecutive years
(Selling Power, 2001-2007) |
| One of the Top 15 U.S. Pharma Companies and among the top 50 globally
(Pharmaceutical Executive, May 2007) |
| Ranked #3 among top pharmaceutical and biotech companies in Pharmaceutical
Executive’s annual strategic industry audit (September 2007) |
| Ranked third in the Pharmaceutical Executive’s fifth annual
industry audit which analyzes financial performance of the top
pharmaceutical and biotech companies publicly traded on stock exchanges.
(September 2006) |
Ranked #27, up from #29, in the Pharmaceutical
Executive's list of the top 50 pharmaceutical companies (May,
2006) |
| Pharmaceutical Executive names Forest as one of the
Fab Four, joining Genentech, Amgen and Johnson & Johnson in
the publication's 2004 audit of the pharmaceutical industry's leading companies
(September 2005) |
| Named an organic "Growth Champion" in Mercer Delta
Consulting’s study, "In Search of Growth: 10 Practices that Create Organic
Growth Champions" (October 10, 2005) |
| Campral®(acamprosate calcium) brand team receives Product Management Today’s
Bronze Award for the product’s 2005 launch (October 2005) |
| Ranked as one of The Best Companies to Sell For by Selling
Power
|
| Ranked #29, up from #32, in the Pharmaceutical Executive's list of
the top 50 pharmaceutical companies (May, 2005) |
| Appeared on the Forbes 500 list |
| The Namenda patient starter kit placed as first runner up in the 2004
Compliance Package of the Year contest (Healthcare Compliance
Packaging Council)
|
| Namenda® (memantine HCl) brand team received Product Management Today's
Honorable Mention for the product's 2004 launch (October 2004)
|
| Recipient of Frost & Sullivan’s 2004 Company of the Year Award
(Neurology category) and Growth Strategy Leadership of the Year Award (Psychiatric
Therapeutics category)
|
| Ranked as one of The Best Companies to Sell For by Selling
Power |
| Ranked among Fortune's Fastest Growing Companies |
| Ranked 32nd up from 38th, in Pharmaceutical Executive's list of
the top 50 pharmaceutical companies
|
| Named one of the Top 50 Manufacturing Companies (Industry Week,
August 1, 2004) |
| Ranked #5 among the Best Performers of the S&P 500 (BusinessWeek,
April 5, 2004) |
| Ranked among the Forbes Platinum list of the 400 best
big companies in America, with special recognition as the best managed company
in the drug and biotechnology industry for 2004 (January 12, 2004) |
| Ranked as one of The Best Companies to Sell For by Selling
Power |
| Ranked among Fortune's Fastest Growing Companies |
| Lexapro® (escitalopram oxalate) brand team named co-Marketing Team of the
Year (2003) by Medical Marketing & Media (December
2003) |
| Pharmaceutical Executive names Forest as one of the Fab Four,
joining Pfizer, Johnson & Johnson, and GlaxoSmithKline in the publication's
annual audit of the pharmaceutical industry's leading companies (September 1,
2003) |
| Ranked 38th up from 40th, in Pharmaceutical Executive's list of
the top 50 pharmaceutical companies
|
| Ranked #1 among the Best Performers of the S&P 500 (BusinessWeek,
Spring 2003) |
| Recipient of the National Wholesale Druggists' Association's
2003 DIANA Award for Best New Product Introduction for Lexapro
|
| Named to the 2003 Forbes A-List, a ranking of the
finest large corporations in the world |
| Ranked in the top half of the Forbes Global 2000, a
comprehensive list of the world's biggest companies |
| Ranked #1 on the Wall Street Journal Honor Roll |
| Ranked in top 100 of the top NYC companies (Newsday) |
| Named Technology MVP by BusinessLI |
| Appeared on the Forbes 500 list |
| Ranked as one of The Best Companies to Sell For by Selling
Power |
| Ranked among Fortune's Fastest Growing Companies |
| Ranked #3 in Pharmaceutical Executive's list of the fastest
growing pharmaceutical companies |
| Ranked 40th in Pharmaceutical Executive's list of the top 50
pharmaceutical companies |
| Appeared on the Forbes 500 list |
| Ranked as one of The Best Companies to Sell For by Selling
Power |
| Ranked among Fortune's Fastest Growing Companies |
| Ranked 40th in Pharmaceutical Executive's list of the top 50
pharmaceutical companies |
| Appeared on the Forbes 500 list |
| Ranked among Fortune's Fastest Growing Companies |
| Fortune magazine named Howard Solomon, Chairman and
CEO, one of America's Most Powerful People |
| Appeared on the Forbes 500 list |